Reactogenicity of a third BNT162b2 mRNA COVID-19 vaccine among immunocompromised individuals and seniors – A nationwide surveyObservational Study Published on 2021-11-012022-10-05 Journal: Clinical immunology (Orlando, Fla.) [Category] SARS, 임상, [키워드] age approved BNT162b2 BNT162b2 mRNA BNT162b2 vaccine booster Booster vaccine COVID-19 vaccine dose elderly evaluate Fever Immunocompromised immunocompromised individual myalgia Older participated reactogenicity recipients reported retrospective cohort SARS-CoV-2 SARS-CoV-2 vaccine Side-effects systemic reaction systemic side effect Vaccine [DOI] 10.1016/j.clim.2021.108860 PMC 바로가기 [Article Type] Observational Study
Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly RecipientCase Report Published on 2021-10-212022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute phase reactant Adverse reactions arthralgia benefit Case report ChAdOx1 ChAdOx1 nCoV-19 clinical decision clinical feature close monitoring condition COVID-19 elderly Elderly patient elevated female Female patients first dose functional impairment increasing age New occur Oxford/AstraZeneca Patient polyarthralgia polymyalgia rheumatica progression reaction reactogenicity recipient rheumatological SARS-CoV-2 severity the patient Treatment Trial vaccination Vaccine [DOI] 10.3390/vaccines9111220 PMC 바로가기 [Article Type] Case Report
Does a lack of vaccine side effects correlate with reduced BNT162b2 mRNA vaccine response among healthcare workers and nursing home residents?Original Article Published on 2021-10-152022-10-28 Journal: Aging Clinical and Experimental Research [Category] COVID-19, MERS, SARS, [키워드] absence all subject anti-receptor-binding domain Anti-spike antibody Antibody titers appear BNT162b2 BNT162b2 mRNA vaccine Care clinician COVID-19 enrolled excluded Frequency greater healthcare healthcare worker help immunogenicity immunogenicity data incidence lack Linear regression model Local log-transformed log-transformed titer Mild mRNA vaccination much lower neutralizing titers nursing homes populations RBD reaction reactogenicity reduced reported Result SARS-CoV-2 severity Side effect Side effects significantly significantly lower statistically significant subject supplementary material systemic reactions systemic reactogenicity the vaccine trials vaccination Vaccine vaccine response [DOI] 10.1007/s40520-021-01987-9 PMC 바로가기 [Article Type] Original Article
The Effects of Heterologous Immunization with Prime-Boost COVID-19 Vaccination against SARS-CoV-2Review Published on 2021-10-112022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome antibody article BNT162b2 categories caused ChAdOx1-S conducted coronavirus COVID-19 COVID-19 pandemic dose Effect Google help Heterologous homologous Homologous vaccine immune response Immunity immunization implication IMPROVE mRNA vaccination mRNA vaccine mRNA-1273 pandemic participant populations reactogenicity recipient regimen robust SARS-CoV-2 searched Serious Adverse Event shown switching systematic review T-cell Response T-cells the vaccine vaccination Vaccine Vaccine hesitancy vaccine safety [DOI] 10.3390/vaccines9101163 PMC 바로가기 [Article Type] Review
Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial청소년 및 노인의 SARS-COV-2 재조합 스파이크 단백질 백신 (NVX-COV2373)의 상이한 용량 요법 : 2 상 무작위 위약 대조 시험Clinical Trial Published on 2021-10-012022-08-13 Journal: PLoS Medicine [Category] Biochemistry, MERS, SARS, 임상, 진단, [키워드] 95% CI 95% confidence interval accumulate addition Administered Adults adverse events age Anti-spike Antibody Response assessments assigned composed conducted convalescent sera coronavirus Day dose dose regimen Efficacy Endpoint Enrollment exceeded Follow-up Formica Frequency full-length SARS-CoV-2 geometric mean geometric mean titer geometric mean titers GMTs group groups identify IgG immune persistence immune response immune responses immunogenic immunogenicity Immunoglobulin Immunoglobulin G include inhibitory concentration intensity intramuscular dose lack limitation Matrix-M1 adjuvant median Mild mild to moderate moderate neutralizing antibody Neutralizing antibody response neutralizing antibody responses NVX-CoV2373 occurred less Older Older adults participant Participants Phase 1 Phase 2 Placebo placebo-controlled placebo-controlled trial primary endpoints Protein Randomized randomized placebo-controlled trial Randomly reactogenicity receive Recombinant spike protein regimen researcher respiratory Respiratory Coronavirus robust safety follow-up SARS-CoV-2 second dose second vaccination secondary endpoint seroconversion rate seroconversion rates severity short duration spike glycoprotein spike glycoproteins Spike protein Support The United States These data Tolerability Treatment Trial Trial registration trimeric United States USA vaccination Vaccine vaccine group wild-type virus [DOI] 10.1371/journal.pmed.1003769 PMC 바로가기 [Article Type] Clinical Trial
Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients고형장기 이식 수혜자에서 SARS-CoV-2 백신 2회 투여의 안전성 및 반응성Article Published on 2021-10-012022-09-12 Journal: Transplantation [Category] MERS, SARS, 진단, [키워드] adjusted age anaphylaxis Antibody Response BNT162b2 Characteristics collected demographics develop diagnose diagnoses dose evaluated female help immunosuppressed patient incidence rate information interquartile range Local mRNA vaccination mRNA vaccine mRNA vaccines mRNA-1273 neurologic one patient Pain participant Poisson regression prospective cohort study reaction reactogenicity recipient recipients recruited rejection reported Safety SARS-CoV-2 Solid solid organ transplant systemic reaction systemic symptom Transplant trials vaccination Vaccine Vaccine hesitancy were excluded [DOI] 10.1097/TP.0000000000003780 PMC 바로가기 [Article Type] Article
Association between Reactogenicity and Immunogenicity after Vaccination with BNT162b2Article Published on 2021-09-272022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome Adverse reaction Adverse reactions age Antibody Response association binding domain BNT162b2 center chose Control coronavirus COVID-19 detectable humoral humoral immune response IgG titer immune response immunogenicity information inhibitory concentration injection median men moderate neutralization activity participant provided RBD reactogenicity resulting robust SARS-CoV-2 SARS-CoV-2 RBD second vaccination severe adverse reaction Sex sick significantly higher university vaccination vaccinee women [DOI] 10.3390/vaccines9101089 PMC 바로가기 [Article Type] Article
Humoral and cellular immunity and the safety of COVID-19 vaccines: a summary of data published by 21 May 2021체액 및 세포 면역과 COVID-19 백신의 안전성: 2021년 5월 21일까지 발표된 데이터 요약Review Published on 2021-09-252022-09-11 Journal: International immunology [Category] SARS, 변종, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 antibody caused Cellular immune response cellular immunity clinical Clinical data clinical study clinical trials consequence coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 deaths dissect Efficacy humoral immune responses indicated Isolation public health Rapid reactogenicity response safety profile SARS-CoV-2 severe acute respiratory syndrome Coronavirus T cell Vaccine Vaccine development variant viral genome sequence [DOI] 10.1093/intimm/dxab061 PMC 바로가기 [Article Type] Review
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty ® )Article Published on 2021-09-242022-10-28 Journal: Vaccines [Category] COVID-19, [키워드] acute respiratory syndrome adverse effect adverse effects Adverse reactions AEs age all subject analyzed antibody association BioNTech BMI BNT162b2 BNT162b2 mRNA boost CLIA collected coronavirus correlation coefficient COVID-19 COVID-19 vaccination ELISA enrolled headache healthcare worker IgG immunogenic immunogenicity LIAISON Linear regression model Local machine learning malaise mRNA vaccine nausea neutralization Neutralization assay occurred Pfizer predict questionnaire reactogenicity S1/S2 SARS-CoV-2 SARS-CoV-2 IgG antibody SARS-COV-2 infection severity Side effects specimen Spike protein subject systemic tested the antibody response the SARS-CoV-2 vaccination was used were measured [DOI] 10.3390/vaccines9101063 PMC 바로가기 [Article Type] Article
Effects of Short-Term Corticosteroid Use on Reactogenicity and Immunogenicity of the First Dose of ChAdOx1 nCoV-19 Vaccine단기 코르티코스테로이드 사용이 ChAdOx1 nCoV-19 백신의 첫 번째 용량의 반응성 및 면역원성에 미치는 영향Comparative Study Published on 2021-09-222022-09-12 Journal: Frontiers in Immunology [Category] SARS, 진단, [키워드] anti-SARS-CoV-2 antibody BNT BNT162b2 Cellular immune response ChAdOx1 nCoV-19 Concentration Corticosteroid COVID-19 dose Effect electrochemiluminescence immunoassay evaluated first dose groups HCW HCWs healthcare worker IFN-γ immunogenicity interferon gamma interquartile range IQR low-dose corticosteroid median prednisolone equivalent Quantitative reactogenicity recruited reduce robust significantly significantly higher Spike protein statistical significance steroid total score vaccination Vaccine was measured [DOI] 10.3389/fimmu.2021.744206 PMC 바로가기 [Article Type] Comparative Study